ASGE Recognized Industry Associate (ARIA) Training Program for Sanofi | June 2022-SANOFI ARIA 2022June15 Session 13 - Day in the Life of a Gastroenterologist Part 2

Video Transcription

Video Summary

In this video, a panel of gastroenterologists discuss various topics related to eosinophilic esophagitis (EOE). They begin by discussing the role of biologic coordinators in GI practices and the challenges associated with coordinating and obtaining approval for biologic medications. Financial factors and insurance coverage play a significant role in treatment decisions, and the panel highlights the importance of educating patients and coordinating care with other specialists, such as allergists and dieticians. They also discuss the different treatment options available for EOE, including diet therapy, proton pump inhibitors (PPIs), topical steroids, and biologic medications. Each treatment option has its own pros and cons, and the decision-making process is individualized based on factors such as the patient's age, symptom severity, and personal preferences. The panel emphasizes the importance of shared decision-making and the need to consider the patient's quality of life and long-term management of EOE. The panel also touches on the challenges and frustrations associated with obtaining insurance approvals and conducting peer-to-peer discussions with insurance companies. They highlight the role of patient advocacy groups in raising awareness about EOE and advocating for better coverage and treatment options. Overall, the video provides insights into the complex and multifaceted management of EOE and the importance of a collaborative and multidisciplinary approach.

Keywords

eosinophilic esophagitis

gastroenterologists

biologic medications

treatment options

insurance coverage

shared decision-making

patient advocacy groups

collaborative approach